baber/WOPTO huggingface dataset:
Patent NZ-267484-A (NZ)
Title: Use of metal ion-porphyrin ring complexes in cigarette filters
Inventor: STAVRIDIS IOANNIS
IPC: B01J20/20
Filed: 1994-06-27
Abstract: PCT No. PCT/GR94/00015 Sec. 371 Date May 24, 1996 Sec. 102(e) Date May 24, 1996 PCT Filed Jun. 27, 1994 PCT Pub. No. WO96/00019 PCT Pub. Date Jan. 4, 1996This invention refers to a method of withholding noxious compounds contained in cigarette smoke (NO, NOx, carcinogenic nitrosocompounds, free radicals, H2O2, CO, aldehydes, and trace elements) which were up to today insufficiently retained by conventional cigarette filters. The method described specifically refers to the enrichment of common convention filters with biological substances of the metal ions (Fe2+, Cu2+, Mg2+) complexed with porphirin ring as well as Fe2+ ions stereospecifically bound to protein molecules, either separately or in combinations. The enrichment of these conventional filters with the abovementioned biological substances alters neither the physical properties of the cigarette smoke (odor, taste and appearance) nor the physical properties of the filter itself.
Patent NZ-270486-A (NZ)
Title: Unsaturated carbohydrate derivatives, polymers thereof and uses
Inventor: BACHMANN FRANK
IPC: C08F20/36
Filed: 1995-02-13
Abstract: The present invention relates to polymerisable derivatives of carbohydrates comprising a compound of formula (I)R1-(COO-Alk)m-(OCONH-R)n-(NHCO)pY-Z (I)wherein R1 is a radically polymerisable hydrocarbon group; m, n and p are 0 or 1; Alk is alkylene having up to 10 carbon atoms; R is a diradical, having up to 20 carbon atoms, of an organic diisocyanate; Z is a monovalent radical, minus a single hydroxy group, of a mono-, di- or tri-saccharide, of an oligosaccharide, of a cyclodextrin (CD) or of an anhydrosaccharide; and Y is -O- or -NH-; with the proviso that when p is zero, m and n are also zero and Y is -NH-; to homopolymers, copolymers, block copolymers, graft copolymers and polymeric networks thereof, to moulded articles, for example contact lenses or biomedicinal articles, comprising the mentioned polymers, as well as to processes for the preparation of the mentioned polymers and articles.
Patent NZ-299249-A (NZ)
Title: Use of an antigenic conjugate of a capsular polysaccharide from streptococcus and a protein component to immunise neonates
Inventor: JENNINGS HAROLD J
IPC: A61K47/48
Filed: 1993-09-24
Abstract: The specification describes the use of a vaccine of an antigenic conjugate molecule for immunizing neonates.  The conjugate comprises a capsular polysaccharide selected from the group derived from a Group streptococcus from type II or type V bacteria and a protein component wherein two or more side chains terminating in sialic acid residues.  The molecular weight of the polysaccharide is at least 5000 Daltons.
Patent NZ-330922-A (NZ)
Title: Hydroxamic acid derivatives substituted by a series of 2-pyrrolidinones, hydantoins, and pyrazolidinones for use with the treatment of diseases related to connective tissue degradation
Inventor: JACOBSEN E JON
IPC: C07D417/12
Filed: 1997-03-03
Abstract: he application provides hydroxamic acid derivatives represented by the compound of formula (I), or pharmaceutical acceptable salts thereof, wherein the compounds inhibit various enzymes from the matrix metalloproteinase family, including collagenase, stromelysin, and gelatinase, and hence are useful for the treatment of matrix metallo endoproteinase diseases such as osteoarthritis, rheumatoid arthritis, septic arthritis, osteopenias such as osteoporosis, tumor metastasis (invasion and growth), periodontitis, gingivitis, corneal ulceration, dermal ulceration, gastric ulceration, and other diseases related to connective tissue degradation.
Patent NZ-336349-A (NZ)
Title: A combination of sodium carbonate and a nonionic silicone surfactant and a nonionic surfactant in a solid block detergent
Inventor: LENTSCH STEVEN E
IPC: C11D3/06
Filed: 1998-01-06
Abstract: The alkaline ware-washing detergent composition comprises: a) an effective soil removing amount of sodium carbonate as the only source of alkalinity and b) an effective soil removing amount of a nonionic surfactant blend comprising: i) a nonionic surfactant comprising a hydrophobic group and an -(EO)x group with x being 1 to 100 and ii) a nonionic silicone surfactant comprising a hydrophobic silicone group and a pendent hydrophilic polyalkylene oxide group; wherein the detergent exhibits enhanced waxy-fatty soil removing capacity and in aqueous solution the detergent exhibits a surface tension at ambient room temperature of less than 0.035N/m.
Patent NZ-500531-A (NZ)
Title: Multicyclic erythromycin derivatives having antibacterial activity
Inventor: OR YAT SUN
IPC: A61K31/7048
Filed: 1998-05-22
Abstract: Multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formulae (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX), (X), or (XI), pharmaceutical compositions comprising a therapeutically effective amount for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of formula (I). Wherein; A, B, D and E is independently a group having the formula -(CH2)m-M-(CH2)n-X, wherein m is 0, 1, 2 or 3 and n is 0, 1, 2 or 3; or one pair of A, B, D and E, selected from the group consisting of A & B, B & D, and D & E, may, when such combinations are possible, additionally combine with the atoms to which they are attached to form a ring selected from the group consisting of benzene, pyridine, pyridazine, pyrimidine, pyrazine, pyrazole, imidazole, triazole, pyrrole, furan, thiophene, oxazole, 1,3-dioxocyclopent-2-ene and 1,4-dioxocyclohex-2-ene; R2 is hydrogen or a hydroxy protecting group; R3 is absent or oxygen when the optional double bond is present; R3 is hydrogen, hydroxy, C1-6acyl or C1-6alkyl optionally substituted with halogen, aryl or heteroaryl, when the optional double bond is absent; and Y and Z are both hydrogen, or one of Y and Z is hydrogen and the other is selected from the group consisting of hydroxy, protected hydroxy, and cladinose, or Y and Z are taken together with the atom to which they are attached to form an oxo group.
Patent NZ-501224-A (NZ)
Title: A one-way suture having barbs on their exterior surfaces and a needle on one or both ends having the capability of putting tension in the tissue when tension is placed on the trailing end of the suture
Inventor: BUNCKE HARRY J
IPC: A61B17/04
Filed: 1998-05-21
Abstract: A surgical needle and suture combination, comprising a surgical needle and a one way suture having a series of exterior barbs providing for gripping of tissue in one direction only. The bards permitting movement of the suture through tissue in the direction the needle is inserted. A detachable connection means securing the trailing end of the needle from the suture, for releasing the needle from the suture when the needle pulls the suture with a prescribed amount of tension. The surgical needle and suture combination avoids loop stitching, thus minimizing scarring.
Patent NZ-502960-A (NZ)
Title: Device for sealing a product temperature holding, reheating or cooling system for conditioning products on a pallet
Inventor: PAUPARDIN MICHEL
IPC: F25D23/06
Filed: 1998-08-30
Abstract: A sealing device for sealing a system for regulating the temperature of products located on a palette placed in a tunnel circulating ventilation air.  The device is characterised in that, in the tunnel (5), in order to avoid air leakage around the products located on the palette, the air tightness is produced by means of a tarpaulin cover (1) arranged to adhere the sides and the top of the products by the effect of the ventilation air pressure circulating in the tunnel.
Patent NZ-508325-A (NZ)
Title: Microemulsion preconcentrates for oral administration containing a piperidine substance P antagonist
Inventor: LANG STEFFEN
IPC: A61K9/22
Filed: 1999-05-26
Abstract: Use of a dispersible pharmaceutical composition of (2R,4S)-N-(1-(3,5-bis(trifluoromethyl)-benzoyl)-2-(4-chlorobenzyl)-4-piperidinyl)-quinoline-4-carboxamide (-a piperidine substance P antagonist), in the form of a microemulsion preconcentrate for use in the treatment of CNS disorders.  Said composition overcomes the previous problems associated with piperidine substance P antagonists, such as variability in drug bioavailability/ resorption levels in individual patients.
Patent NZ-508517-A (NZ)
Title: Fungicidal combinations comprising glyoxalic acid methyl ester-o-methyloxime derivatives
Inventor: ZURFLUEH RENE
IPC: A01N37/50
Filed: 1999-06-04
Abstract: A method of combating phytopathogenic diseases on crop plants which comprises applying to the crop plants or the locus thereof being infested with said phytopathogenic disease, in admixture or separately, an effective amount of a synergistic combination of a first component a) 2-[á-{[(á-methyl-3-trifluoromethyl-benzyl)imino]-oxy}-o-tolyl]-glyoxalic acid methyl ester-O-methyloxime (I) in association with b) a second component selected from either an anilide of formula IIB where, R1 is fluorine or chlorine; or a carbamate of formula IIC where, X is N or CH, and R2 is 4-CH3, 4-Cl or 2,4-dichloro; or a compound II D methyl(2)-2-{2-[6-(trifluoromethyl)pyrid-2-yloxymethyl]-phenyl}-3-methoxyacrylate; or a compound IIE (E)-N-methyl-2-[2-(2,5-dimethylphenoxymethyl)phenyl]-2-methoxy-iminoacetamide; or a compound of formula IIF where, R3 is methyl or ethyl; or a (S)-valinamide of formula IIG where, R4 is isopropyl, sec-butyl or tert-butyl, and R5 is 4-chlorophenyl, 4-methylphenyl, 4-methoxyphenyl or â-naphthyl; or a (S)-valinamide of formula IIH where, R6 is isopropyl, sec-butyl or tert-butyl, R7 is halogen, methyl or methoxy and n is 0 to 2; or a compound IIJ  N-methyl-2-[2-{alpha-methyl-3-(trifluoromethyl)benzyloximinomethyl}phenyl]-2-methoximinoacetamide; or a compound of formula IIK where, R8 is halogen or C1-C4-alkyl; or a compound IIL N-(3'-(1'-chloro-3-methyl 2'-oxopentan))-3,5-dichloro-4-methylbenzamide; or a compound IIM (S)-1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one; or a compound of formula IIN; or a compound of formula IIP; or a compound IIQ N-methyl-2-[-á-[(á-methyl-3-trifluoromethyl-benzyl)imino]-oxy}-o-tolyl]-glyoxalic acidamide-O-methyloxime.
Patent NZ-510026-A (NZ)
Title: Plant ethylene response inhibition compounds and complexes
Inventor: DALY JAMES
IPC: A23L5/40
Filed: 1999-06-30
Abstract: A method of minimizing impurities capable of reversibly binding  to  plant ethylene receptor sites by  competitively displacing  said impurities using an encapsulated  compound. Said method comprising reacting, in an inert environment,  a metal  amide  salt, a halogenated carbene  and  a  molecular encapsulation agent, optionally in the presence  of  a  non- reactive   solvent,  to  form  said  encapsulated  compound, having the structure (I), wherein, n is a number from  1  to 4,  and R is selected from the group consisting of hydrogen, saturated  or  unsaturated alkyl, hydroxy, halogen,  alkoxy, amino and carboxy.
Patent NZ-511543-A (NZ)
Title: Line spacer for power transmission lines with movable jaw parts moved against fixed jaw parts at either end of spacer body
Inventor: MCKINNON BRUCE RAYMOND
IPC: H02G7/12
Filed: 1999-11-02
Abstract: A line spacer for use between power transmission lines to maintain the lines at a set spacing from each other includes at least two spaced jaws and a lever action closure mechanism operable to close the jaws after engaging of the spacer onto adjacent lines, to fix the spacer in position between the lines.
Patent NZ-523027-A (NZ)
Title: Methods of pre-selecting a polymerizable fluid formed into an intraocular lens
Inventor: TERWEE THOMAS HENRICUS MARIE
IPC: A61P27/02
Filed: 2001-05-23
Abstract: A method of restoring the vision of an eye having an impaired lens with an artificial lens implant. The method involves replacing the lens by a polymerizable material injected into the emptied lens capsule and thereby providing a new lens implant with a predetermined refractive value, while admitting the possibility of controlling and adjusting the refractive value of the eye during the surgical process.
Patent NZ-530315-A (NZ)
Title: Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
Inventor: JOHNSON MARK E
IPC: A61P35/00
Filed: 2002-07-10
Abstract: A pharmaceutical composition comprising an adjuvant encapsulated in biodegradable polymeric microspheres and a pharmaceutically acceptable carrier, wherein the adjuvant is encapsulated without antigen by: a) solubilizing the adjuvant in the presence of a hydrophobic ion pairing (HIP) agent and an organic solvent to produce an organic phase comprising the adjuvant; b) dissolving the polymer in the organic solvent or in the organic phase; and c) preparing microspheres from a polymer solution, wherein the polymer solution comprises the organic phase, the adjuvant and the polymer.
Patent NZ-532526-A (NZ)
Title: Compositions comprising a glycoprotein having a Fc region
Inventor: PRESTA LEONARD G
IPC: A61K38/00
Filed: 2002-10-22
Abstract: Disclosed are compositions comprising a glycoprotein having an Fc region, wherein about 80-100% of the glycoprotein in the composition comprises a mature core carbohydrate structure which lacks fucose, attached to the Fc region of the glycoprotein. The preferred glycoprotein is an antibody or immunoadhesin.
Patent NZ-533301-A (NZ)
Title: Damping element
Inventor: STUDER ARMIN
IPC: F16F1/12
Filed: 2001-12-07
Abstract: Disclosed is a damping element (1) comprising two spring elements (2; 4), which are coaxial or parallel to a longitudinal axis (3), and connecting parts (5; 6), which can be connected to the spring elements while being axially located at the ends thereof, where the first spring element (2) has a spring rate F and the second spring element (4) has a spring rate f, and where spring rates F and f differ from one another. Also disclosed is a device for stabilizing adjacent vertebral bodies comprising N pedicel screws or pedicel hooks (12) and at least one pedicel screw or one pedicel hook comprises receiving means (13) which simultaneously allow receiving two parallel affixation means (7), and where an element (14) acting as a spring is used for affixation between the at least one pedicel screw or pedicel hook comprising receiving means, and another adjacent pedicel screw or pedicel hook.
Patent NZ-546991-A (NZ)
Title: 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as PARP inhibitors
Inventor: MABIRE DOMINIQUE JEAN-PIERRE
IPC: C07D409/12
Filed: 2004-11-18
Abstract: The disclosure relates to substituted 2-quinolinones and 2-quinoxalinones of formula (I), the N-oxide forms, the addition salts and the stereo-chemically isomeric forms thereof, wherein the variables are defined in the specification. Also disclosed is the preparation of said compounds and their use as PARP inhibitors in the treatment of cancer and arthritis.
Patent NZ-549638-A (NZ)
Title: Method of detecting allergen
Inventor: AKIMOTO MASANOBU
IPC: C07K16/16
Filed: 2005-03-04
Abstract: Provided is a method and kit for detecting allergens in a test target product by using 2 or more monoclonal antibodies recognizing native and denatured milk allergens, or native and denatured albumen allergens, said method comprising: contacting a sample or extract of said product with: 2 or more monoclonal antibodies recognizing native and denatured alpha s1 casein, or at least one monoclonal antibody recognizing native alpha s1 casein and at least one monoclonal antibody recognizing denatured alpha s1 casein; 2 or more monoclonal antibodies recognizing native and denatured beta-lactoglobulin, or at least one monoclonal antibody recognizing native beta-lactoglobulin and at least one monoclonal antibody recognizing denatured beta-lactoglobulin; 2 or more monoclonal antibodies recognizing native and denatured ovalbumin, or at least one monoclonal antibody recognizing native ovalbumin and at least one monoclonal antibody recognizing denatured ovalbumin; and/or 2 or more monoclonal antibodies recognizing native and denatured ovomucoid, or at least one monoclonal antibody recognizing native ovomucoid and at least one monoclonal antibody recognizing denatured ovomucoid; and detecting any binding between said monoclonal antibodies and allergens present in the test target product sample or extract.
Patent NZ-550234-A (NZ)
Title: 2-alkylidene-18,19-dinor-vitamin D compounds
Inventor: DELUCA HECTOR F
IPC: A61P35/00
Filed: 2005-02-04
Abstract: Disclosed is a 2-alkylidene-18,19-dinor-vitamin D compound having the formula (I) where Y1 and Y2, which may be the same or different, are each selected from the group consisting of hydrogen and a hydroxy-protecting group, R6 and R8, which may be the same or different, are each selected from the group consisting of hydrogen, alkyl, hydroxyalkyl and fluoroalkyl, or, when taken together represent the group -(CH2)x- where x is an integer from 2 to 5, and where the group R is represented by a branched alkyl group optionally substituted with a hydroxy group as defined in the specification. Also disclosed is a composition comprising said compound and the use of the compound in the manufacture of a medicament.
Patent NZ-550468-A (NZ)
Title: Zeolitic microporous crystalline material with an Linde Type A structure (ITQ-29), preparation method thereof and uses of same in organic compound separation and transformation processes
Inventor: CORMA CANOS AVELINO
IPC: C01B39/04
Filed: 2005-03-09
Abstract: Disclosed is a crystalline material with a Linde type A structure of zeolitic nature that in its calcined and anhydrous state, and in the absence of defects in its crystalline lattice, has the empirical formulas of x (M1/nXO2): z ZO2: y GeO2: (1-y) SiO2, wherein x has a value of less than 0.15, and can equal zero; z has a value of between 0 and 0.1; y has a value of between 0 and 1; M represents one or more +n-charged inorganic cations; X represents one or more +3 oxidation state chemical elements (Al, B, Ga, Fe); and Z represents one or more +4 oxidation state cations different from silicon and germanium. Also disclosed is the method of producing the said crystalline material. Also disclosed is the use of the above material as a component of catalysts in acid catalysis processes or as a metal or oxide support in separation and absorption/adsorption processes.
Patent NZ-554183-A (NZ)
Title: Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition
Inventor: WAGNER ANDREAS
Filed: 2005-10-14
Abstract: Disclosed is a pharmaceutical composition comprising an active ingredient included in liposomes, characterized in that the liposomes have, in their interior, an aqueous medium having a pH in the range of 2.5-5.5 and contain therein at least one protonated active ingredient which has a direct or indirect relaxing effect on the smooth muscles and an aqueous medium having a neutral or alkaline pH is present outside the liposomes, with the result that an H+ gradient is present between the inside and outside of the liposomes.
Patent NZ-563065-A (NZ)
Title: Thermosetting powder compositions
Inventor: MOENS LUC
IPC: C08L67/00
Filed: 2006-05-15
Abstract: A thermosetting powder composition comprising a binder composition is disclosed, which comprises: from 99 to 55 parts by weight, calculated on the total weight of polyesters, of at least one amorphous polyester (A) which comprises, with respect to the total amount of acids, from 50 to 100 mol % of isophthalic acid and optionally from 0 to 50 mol % of at least one other aliphatic, cycloaliphatic and/or aromatic polycarboxylic acid and, with respect to the total amount of alcohols, from 70 to 100 mol % of neopentyl glycol and optionally from 0 to 30 mol % of at least one other aliphatic and/or cycloaliphatic polyol, said amorphous polyester (A) having a number average molecular weight of from 1100 to 11500; and from 1 to 45 parts by weight, calculated on the total weight of polyesters, of at least one amorphous polyester (B) which comprises, with respect to the total amount 15 of acids, from 75 to 100 mol % of at least one straight-chain saturated di-carboxylic aliphatic acid having from 4 to 14 carbon atoms and optionally from 0 to 25 mol % of at least one other aliphatic, cycloaliphatic and/or aromatic polycarboxylic acid and, with respect to the total amount of alcohols, from 75 to 100 mol % of at least one branched chain aliphatic diol and optionally from 0 to 25 mol % of at least one 20 other aliphatic or cycloaliphatic polyol, said amorphous polyester (B) having a number average molecular weight of from 1100 to 17000. These thermosetting powder compositions give coatings having remarkable weatherability, excellent mechanical properties and an outstanding flow.
Patent NZ-564485-A (NZ)
Title: Pole leaning elevated work platform
Inventor: PATTISON GRAEME
Filed: 2007-12-18
Abstract: A work platform 1 includes a standing platform 5 that is hinge mounted near the upper end of a ladder 2, and a support arm 7, which may also be in the form of a ladder, that is hinge mounted to the other side of the platform and has a pole clamp mounted on its other end. Once the pole clamp is clamped about a pole or roadway structure, the ladder extended to an appropriate height, and the angle between the support arm and the platform locked, then the platform 5 provides a stable and horizontal elevated standing surface for a workman.
Patent NZ-570556-A (NZ)
Title: Use of rylenes as markers for liquids
Inventor: GESSNER THOMAS
IPC: C07D471/06
Filed: 2007-02-23
Abstract: Disclosed is the use of rylene derivatives of the general formula (I) as markers for liquids, where the symbols and indices are defined in the specification. Also disclosed is a rylene derivative of formula (I), a mineral oil comprising at least one compound of formula (I), a process for marking mineral oils wherein a compound of formula (I) is added to the mineral oil and a process of identifying mineral oils comprising at least one compound of formula (I).
Patent NZ-570617-A (NZ)
Title: Developing an instant transaction account application authorization decision based on a rewards program
Inventor: CRAWFORD STACEY J
IPC: G06Q40/00
Filed: 2007-01-25
Abstract: Disclosed is a system to provide fraud control when granting instant credit. The system comprises of: a tangible, non-transitory memory communicating with a processor for issuing a transaction account. The memory includes instructions which cause the processor to: receive an instant transaction account application containing information about an applicant from a partner service provider; develop an instant transaction account authorization decision based on the instant application; develop by an instant transaction account authorization decision based on information associated with a rewards program provided by the partner service provider; and provide an instant transaction account code in response to the authorization decision indicating approval of the instant transaction account application.